All companies
Visit website
Immergo Labs
OperatingImmergo Labs, Inc.
Healthcare · Founded 2022
Redefining telehealth for physical therapy
Post-money valuation ⓘ
$19.7M
As of Dec 2022 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$154,108
Across 1 round since 2022
Latest share price
$2.24
Reg CF Offering (2022) offering price
Financials
FY2020–FY2024 · from SEC filings · hover any figure for its source$0
2020
$0
$13K
2021
$0
−$84K
2022
$43K
−$97K
2023
$301K
−$59K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$0
$0
$42,832
$300,812
Cost of goods sold
$0
$0
$8,253
$12,397
$238,295
Gross margin
—
—
—
71%
21%
Net income
$0
$13,456
-$83,533
-$97,195
-$59,493
Taxes paid
$0
$0
$1,600
$848
$800
Balance sheet
Cash
$0
$14,981
$94,653
$49,557
$30,699
Accounts receivable
$0
$0
$0
$0
$0
Total assets
$0
$14,981
$97,599
$49,557
$54,076
Short-term debt
$0
$0
$900
$12,099
$1,431
Long-term debt
$0
$1,294
$0
$20,000
$147,000
Total liabilities
$0
$1,294
$900
$32,099
$148,431
Other
Headcount
—
3
3
3
6
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$19.7M
post-money
Reg CF Offering (2022)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $154.1K / $1.1MInvestors 113Post-money $19.7M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 3 of 4 annual reports (FY2022–FY2025)
113 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001947217Share price $2.24
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.